Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Michael Overman"'
Autor:
Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, Ray Chacko, Jennifer Peterson, Brandon G. Smaglo, Robert A. Wolff, Shubham Pant, Michael S. Lee, Jason Willis, Michael Overman, Sudheer Doss, Lynn Matrisian, Mark W. Hurd, Rebecca Snyder, Matthew H. G. Katz, Huamin Wang, Anirban Maitra, John Paul Shen, Dan Zhao
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract The relevance of KRAS mutation alleles to clinical outcome remains inconclusive in pancreatic adenocarcinoma (PDAC). We conducted a retrospective study of 803 patients with PDAC (42% with metastatic disease) at MD Anderson Cancer Center. Ove
Externí odkaz:
https://doaj.org/article/07e4c9e5f98d41abaef00dd9155ae1ad
Autor:
Gabriel Lopez, Cathy Eng, Michael Overman, David Ramirez, Wenli Liu, Curtiss Beinhorn, Pamela Sumler, Sarah Prinsloo, Yisheng Li, Minxing Chen, Eduardo Bruera, Lorenzo Cohen
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/667d3f521aa441a0888758f1c0f4ac92
Autor:
Gabriel Lopez, Cathy Eng, Michael Overman, David Ramirez, Wenli Liu, Curtiss Beinhorn, Pamela Sumler, Sarah Prinsloo, Yisheng Li, Minxing Chen, Eduardo Bruera, Lorenzo Cohen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract This pilot randomized controlled trial investigated massage therapy for symptomatic relief of chemotherapy-induced peripheral neuropathy (CIPN) to determine the ideal weekly frequency and number of weeks of providing massage. We evaluated th
Externí odkaz:
https://doaj.org/article/8cbd2c2f3c34417cb5bd46831d3b337c
Autor:
Aung Naing, Funda Meric-Bernstam, Michael Overman, Bettzy Stephen, David S Hong, Sarina A Piha-Paul, Daniel D Karp, Kanwal P Raghav, Dipti Jain, Dilichukwu O Chudy Onwugaje, Abdulrahman Abonofal, Anneleis F Willett, Brandon Smaglo, Ryan W Huey, Gauri R Varadhachary
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/c4da560a7c1a4e3aa6e20aa8fd7c06ec
Autor:
Akihito Kawazoe, Kohei Shitara, Chiara Cremolini, Giovanni Fucà, Sara Lonardi, Filippo Pietrantonio, Francesca Corti, Samuel J Klempner, Magali Svrcek, Thierry André, Giuseppe Curigliano, Michael Overman, Francesca Bergamo, Elisabetta Fenocchio, Massimiliano Salati, Margherita Ambrosini, Giovanni Randon, Lisa Salvatore, Romain Cohen, Raphael Colle, Priya Jayachandran, Maria Elena Elez, Marwan Fakih, Aakash Tushar Shah, Joseph Chao, Matthew Emmett, Marc Díez García, Giacomo Mazzoli, Leonardo Provenzano, Keigo Chida, Veronica Conca
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/0a3c47b59e654946a72b34ac617e8c57
Autor:
Jane E. Rogers, Jonathan D. Mizrahi, Lianchun Xiao, Chirayu Mohindroo, Rachna T. Shroff, Robert Wolff, Gauri R. Varadhachary, Milind M. Javle, Michael Overman, David R. Fogelman, Kanwal P. S. Raghav, Shubham Pant, Florencia McAllister
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5406-5415 (2020)
Abstract Background Gemcitabine (GEM) plus nab‐paclitaxel (NabP) (GEM 1000 mg/m2 IV over 30 minutes + NabP 125 mg/m2 IV given days 1, 8, and 15 every 28 days) is one of the two standard of care combination therapies for metastatic pancreatic ductal
Externí odkaz:
https://doaj.org/article/661f185a502f41a69c6a00dc6f1e1360
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/342bacbd54c44659b86f463205e830c3
Autor:
Chiara Cremolini, Giovanni Fucà, Sara Lonardi, Federica Morano, Francesca Corti, Giuseppe Curigliano, Michael Overman, Elisabetta Fenocchio, Massimiliano Salati, Margherita Ambrosini, Lisa Salvatore, Rossana Intini, Priya Jayachandran, Javier Ros, Gabriele Infante, Maria Elena Elez, Marwan Fakih, Aakash Tushar Shah, Floriana Nappo, Silvia Damian, Rosalba Miceli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/a7b576cb763446df83fea7d4010f14b3
Autor:
Michael Overman, Richard E Davis, Pankaj Vats, Chandan Kumar-Sinha, Niharika B Mettu, Charles D Lopez, Veerendra Munugalavadla, Priti Patel, Lin Tao, Sattva Neelapu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundThe immunosuppressive desmoplastic stroma of pancreatic cancer represents a major hurdle to developing an effective immune response. Preclinical studies in pancreatic cancer have demonstrated promising anti-tumor activity with Bruton tyrosi
Externí odkaz:
https://doaj.org/article/50d0394471cc4ce4983fa47de5d9edeb
Autor:
Allan A Lima Pereira, Maria Pia Morelli, Michael Overman, Bryan Kee, David Fogelman, Eduardo Vilar, Imad Shureiqi, Kanwal Raghav, Cathy Eng, Shanequa Manuel, Shadarra Crosby, Robert A Wolff, Kimberly Banks, Richard Lanman, AmirAli Talasaz, Scott Kopetz, Van Morris
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183949 (2017)
Circulating cell-free DNA (cfDNA) isolated from the plasma of cancer patients (pts) has been shown to reflect the genomic mutation profile of the tumor. However, physician and patient assessment of clinical utility of these assays in patients with me
Externí odkaz:
https://doaj.org/article/01cf886af3f24f81a41645e8f9fd15e1